Cargando…

Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft

BACKGROUND: Cancer therapies that kill cancer cells without affecting normal cells is the ultimate mode of treating cancers. The VP3, an avian virus-derived protein, can specifically initiate cell death through several signal transduction pathways leading to apoptosis. In cancer, chemoresistance and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Ruzila, Allaudin, Zeenathul Nazariah, Abdullah, Rasedee, Mohd Lila, Mohd-Azmi, Nik Abd. Rahman, Nik-Mohd-Afizan, Abdul Rahman, Sheikh-Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944445/
https://www.ncbi.nlm.nih.gov/pubmed/27411985
http://dx.doi.org/10.1186/s12885-016-2530-8
_version_ 1782442766526054400
author Ismail, Ruzila
Allaudin, Zeenathul Nazariah
Abdullah, Rasedee
Mohd Lila, Mohd-Azmi
Nik Abd. Rahman, Nik-Mohd-Afizan
Abdul Rahman, Sheikh-Omar
author_facet Ismail, Ruzila
Allaudin, Zeenathul Nazariah
Abdullah, Rasedee
Mohd Lila, Mohd-Azmi
Nik Abd. Rahman, Nik-Mohd-Afizan
Abdul Rahman, Sheikh-Omar
author_sort Ismail, Ruzila
collection PubMed
description BACKGROUND: Cancer therapies that kill cancer cells without affecting normal cells is the ultimate mode of treating cancers. The VP3, an avian virus-derived protein, can specifically initiate cell death through several signal transduction pathways leading to apoptosis. In cancer, chemoresistance and cell survivability implicate the cell surface protein, CD147. METHODS: In this study, transfection of VP3 and silencing of CD147 genes was achieved through the treatment of tumors with pVIVO1-GFP/VP3 (VP3), psiRNA-CD147/2 (shCD147/2), and their combination of CT26 colon cancer cell-induced in mice. The effectiveness of tumor-treatment was ascertained by electrophoresis, TUNEL assay, and flow cytometry analysis. While histopathological and biochemical analysis were used as toxic side effect identification. RESULTS: The tumor growth delay index (TGDI) after treatment with VP3, shCD147/2, and their combination treatments increased by 1.3-, 1.2-, 2.0- and 2.3-fold respectively, over untreated control. The VP3-shCD147/2 combination treatment was more efficacious then either VP3 or shCD147/2 alone in the retardation of mouse CT26 colorectal cell tumor allograft. CONCLUSION: The antitumor effect of the combination treatment is the result of synergistic effects of VP3 and shCD147/2 on the tumor cells resulting in apoptosis. Thus, the study shows that combination of VP3 and shCD147/2 treatment can be developed into a potential approach for anticolorectal cancer treatment regimen. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2530-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4944445
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49444452016-07-15 Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft Ismail, Ruzila Allaudin, Zeenathul Nazariah Abdullah, Rasedee Mohd Lila, Mohd-Azmi Nik Abd. Rahman, Nik-Mohd-Afizan Abdul Rahman, Sheikh-Omar BMC Cancer Research Article BACKGROUND: Cancer therapies that kill cancer cells without affecting normal cells is the ultimate mode of treating cancers. The VP3, an avian virus-derived protein, can specifically initiate cell death through several signal transduction pathways leading to apoptosis. In cancer, chemoresistance and cell survivability implicate the cell surface protein, CD147. METHODS: In this study, transfection of VP3 and silencing of CD147 genes was achieved through the treatment of tumors with pVIVO1-GFP/VP3 (VP3), psiRNA-CD147/2 (shCD147/2), and their combination of CT26 colon cancer cell-induced in mice. The effectiveness of tumor-treatment was ascertained by electrophoresis, TUNEL assay, and flow cytometry analysis. While histopathological and biochemical analysis were used as toxic side effect identification. RESULTS: The tumor growth delay index (TGDI) after treatment with VP3, shCD147/2, and their combination treatments increased by 1.3-, 1.2-, 2.0- and 2.3-fold respectively, over untreated control. The VP3-shCD147/2 combination treatment was more efficacious then either VP3 or shCD147/2 alone in the retardation of mouse CT26 colorectal cell tumor allograft. CONCLUSION: The antitumor effect of the combination treatment is the result of synergistic effects of VP3 and shCD147/2 on the tumor cells resulting in apoptosis. Thus, the study shows that combination of VP3 and shCD147/2 treatment can be developed into a potential approach for anticolorectal cancer treatment regimen. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2530-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-13 /pmc/articles/PMC4944445/ /pubmed/27411985 http://dx.doi.org/10.1186/s12885-016-2530-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ismail, Ruzila
Allaudin, Zeenathul Nazariah
Abdullah, Rasedee
Mohd Lila, Mohd-Azmi
Nik Abd. Rahman, Nik-Mohd-Afizan
Abdul Rahman, Sheikh-Omar
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
title Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
title_full Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
title_fullStr Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
title_full_unstemmed Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
title_short Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
title_sort combination of vp3 and cd147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944445/
https://www.ncbi.nlm.nih.gov/pubmed/27411985
http://dx.doi.org/10.1186/s12885-016-2530-8
work_keys_str_mv AT ismailruzila combinationofvp3andcd147knockdownenhanceapoptosisandtumorgrowthdelayindexincolorectaltumorallograft
AT allaudinzeenathulnazariah combinationofvp3andcd147knockdownenhanceapoptosisandtumorgrowthdelayindexincolorectaltumorallograft
AT abdullahrasedee combinationofvp3andcd147knockdownenhanceapoptosisandtumorgrowthdelayindexincolorectaltumorallograft
AT mohdlilamohdazmi combinationofvp3andcd147knockdownenhanceapoptosisandtumorgrowthdelayindexincolorectaltumorallograft
AT nikabdrahmannikmohdafizan combinationofvp3andcd147knockdownenhanceapoptosisandtumorgrowthdelayindexincolorectaltumorallograft
AT abdulrahmansheikhomar combinationofvp3andcd147knockdownenhanceapoptosisandtumorgrowthdelayindexincolorectaltumorallograft